DKSH and Quantum-Si Announce Strategic Partnership to Bring Next-Generation Protein Sequencing to Taiwan

Taipei, Taiwan, April 2, 2025 – DKSH Business Unit Technology has entered a strategic partnership with Quantum-Si to introduce their Next-Generation Protein Sequencing™ solutions in Taiwan. Through this collaboration, DKSH will provide end-to-end support, including sales and marketing, application engineering, training, and after-sales services, bringing advanced proteomic technologies closer to researchers and laboratories in the region.

Quantum-Si is a leader in biomolecular innovation, pioneering post-genomic research with its cutting-edge Next-Generation Protein Sequencing™ technology. The partnership leverages DKSH’s in-depth market expertise, strong customer network, and comprehensive service capabilities, combined with Quantum-Si’s trailblazing portfolio of proteomics instrumentation, including the “Platinum” products.

Ben Lin, General Manager, Semiconductor, Photovoltaic & Electronics and Industrial Materials & Supplies, Business Unit Technology, DKSH Taiwan, said: “We are delighted to partner with Quantum-Si to expand our market presence and unlock new growth opportunities. With DKSH’s expertise in market research, marketing and sales, and customer service, this partnership will enable us to strengthen Quantum-Si’s reach and raise industry know-how to meet evolving customer needs.”

Jeff Hawkins, Chief Executive Officer, Quantum-Si, stated: “We are excited to collaborate with DKSH to bring Quantum-Si’s Next-Generation Protein Sequencing™ technology to researchers in Taiwan. DKSH’s strong presence and expertise in the region will expand access to the Platinum family of instruments, empowering scientists with cutting-edge protein sequencing capabilities.”

This partnership aims to drive scientific innovation and expand access to next-generation solutions in Taiwan’s life sciences sector. By combining DKSH’s local expertise with Quantum-Si’s technological leadership, both companies are committed to delivering exceptional value and advancing proteomics research.